Implantable cardioverter-defibrillator therapy in Australia, 2002-2015

被引:17
|
作者
Blanch, Bianca [1 ]
Lago, Luise P. [2 ]
Sy, Raymond [3 ]
Harris, Phillip J. [4 ]
Semsarian, Christopher [1 ,3 ,4 ]
Ingles, Jodie [1 ,3 ,4 ]
机构
[1] Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Sydney, NSW, Australia
[2] Univ Wollongong, Ctr Hlth Res, Wollongong, NSW, Australia
[3] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[4] Royal Prince Alfred Hosp, Sydney, NSW, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
PRIMARY PREVENTION; CARDIAC-ARREST; HEART-FAILURE; UNITED-STATES; AGE; DEATH; ASSOCIATION; COMMUNITY; OUTCOMES; QUALITY;
D O I
10.5694/mja17.01183
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To quantify the number of implantable cardioverter-defibrillator (ICD) procedures in Australia by year, patient age and sex, and to estimate age group-specific population rates and the associated costs. Design, setting: Retrospective observational study; analysis of Australian National Hospital Morbidity Database hospital procedures data. Participants: Patients with an ICD insertion, replacement, adjustment, or removal procedure code, July 2002 - June 2015. Main outcome measures: Number of ICD procedures by procedure year, patient age (0-34, 35-69, 70 years or more) and sex; age group-specific population procedure rates; number of procedures associated with complications. Results: The number of ICD procedures increased from 1844 in 2002-03 to 6504 in 2014-15; more than 75% of procedures were in men. In 2014-15, the ICD insertion rate for people aged 70 years or more was 78.1 per 100 000 population, 22 per 100 000 for those aged 35-69 years, and 1.40 per 100 000 people under 35. The reported complication rate decreased from 45% in 2002-03 to 19% in 2014-15, party because of a change in the coding of complications. The number of removals corresponded to at least 4% of the number of insertions each year. The aggregate cost of hospitalisations with an ICD procedure during 2011-14 was $445 644 566. Conclusion: ICD procedures are becoming more frequent in Australia, particularly in people aged 70 or more. Patterns of care associated with ICD therapy, particularly patient- and hospital-related factors associated with adverse events, should be investigated to better understand and improve patient outcomes.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 50 条
  • [41] Persistent sex disparities in implantable cardioverter-defibrillator therapy
    Johnson, Amber E.
    Adhikari, Shubash
    Althouse, Andrew D.
    Thoma, Floyd
    Marroquin, Oscar C.
    Koscumb, Stephen
    Hausmann, Leslie R. M.
    Myaskovsky, Larissa
    Saba, Samir F.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2018, 41 (09): : 1150 - 1157
  • [42] Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
    Yalta, Kenan
    Yetkin, Erta
    CJC OPEN, 2022, 4 (09) : 823 - 824
  • [43] Celivarone in patients with an implantable cardioverter-defibrillator: Adjunctive therapy for the reduction of ventricular arrhythmia-triggered implantable cardioverter-defibrillator interventions
    Gojkovic, Olivera
    Aliot, Etienne M.
    Capucci, Alessandro
    Connolly, Stuart J.
    Crijns, Harry
    Hohnloser, Stefan H.
    Kulakowski, Piotr
    Roy, Denis
    Radzik, David
    Singh, Bramah N.
    Kowey, Peter R.
    HEART RHYTHM, 2012, 9 (02) : 217 - U2
  • [44] Successful extravascular implantable cardioverter-defibrillator implantation in a patient with recurrent transvenous implantable cardioverter-defibrillator erosion
    Robinson, Andrea
    Billakanty, Sreedhar
    Fu, Eugene
    Amin, Anish
    HEART RHYTHM O2, 2024, 5 (04): : 243 - 245
  • [45] Pacemaker/implantable cardioverter-defibrillator problem: Right ventricular lead missensing in a biventricular implantable cardioverter-defibrillator
    Otten, Richard F.
    Foreman, Lynne D.
    Groh, William J.
    HEART RHYTHM, 2008, 5 (01) : 158 - 159
  • [46] The implantable cardioverter-defibrillator: postcode prescribing in the UK 1998-2002
    Cunningham, AD
    Plummer, CJ
    McComb, JM
    Lord, SW
    Cunningham, MW
    Toussaint, JM
    Rickards, AF
    HEART, 2005, 91 (10) : 1280 - 1283
  • [47] Preventing premature implantable cardioverter defibrillator therapy (ICD) by using the wearable cardioverter-defibrillator (WCD)
    Waessnig, N.
    Guenther, M.
    Quick, S.
    Wiedemann, S.
    Heidrich, F.
    Sveric, K.
    Strasser, R.
    Ibrahim, K.
    Speiser, U.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1378 - 1378
  • [48] MORTALITY BENEFITS AND THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    SWEENEY, MO
    RUSKIN, JN
    CIRCULATION, 1994, 89 (04) : 1851 - 1858
  • [49] Efficacy of the implantable cardioverter-defibrillator in the elderly
    Panotopoulos, PT
    Axtell, K
    Anderson, AJ
    Sra, J
    Blanck, Z
    Deshpande, S
    Biehl, M
    Keelan, ET
    Jazayeri, MR
    Akhtar, M
    Dhala, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (03) : 556 - 560
  • [50] Subcutaneous Implantable Cardioverter-Defibrillator Technology
    Gupta, Anurag
    Al-Ahmad, Amin
    Wang, Paul J.
    HEART FAILURE CLINICS, 2011, 7 (02) : 287 - +